FDA Approves Novo Nordisk’s Ozempic for Chronic Kidney Disease Treatment in Type 2 Diabetes Patients
Washington: The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic for the treatment of chronic kidney disease in patients who also have Type 2 diabetes. This approval allows Ozempic to be utilized in reducing the risk of